News
Bristol-Myers Squibb and Roche Enter into a Clinical Collaboration Agreement
Bristol-Myers Squibb Company announced it has entered in to a clinical collaboration agreement with Roche to evaluate the utility of Bristol-Myers Squibb’s CTLA-4 inhibitor, YERVOY (ipilimumab), in combination with Roche’s investigational oral BRAF inhibitor, vemurafenib, in treating patients with...
News
Cytokinetics to Present Clinical Data Relating to CK-2017357
Cytokinetics, Incorporated announced that two posters relating to CK-2017357 are scheduled to be presented at the 22nd Annual Sessions of the Society for Vascular Medicine to be held June 2-4, 2011 at the Seaport Hotel in Boston, MA. ...
News
AstraZeneca signs agreement in Japan with Daiichi Sankyo
AstraZeneca announced a co-promotion agreement in Japan with Daiichi Sankyo for denosumab for the treatment of bone disorders stemming from bone metastasis. AstraZeneca and Daiichi Sankyo will co-promote denosumab after it is approved for use in...
News
Lend Lease sells King of Prussia mall
Lend Lease announced it has entered into an agreement to sell its interest in the King of Prussia shopping mall to the Morgan Stanley Prime Property Fund at a gross valuation of US$1.25 billion. Lend Lease has a 50%...
News
CHMP Issues Positive Opinion for Merck’s VICTRELIS
Merck, known as MSD outside the United States and Canada, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion under accelerated assessment1 recommending approval of the...
News
Takeda to Acquire Nycomed
Takeda Pharmaceutical Company Limited jointly announced that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company for 9.6 billion Euro on a cash-free, debt-free basis. The boards of directors of...
News
RAUMEDIC and Sartorius Stedim Biotech Sign Partnership Agreement
Sartorius Stedim Biotech (SSB), an international leading pharma and biotech supplier, and RAUMEDIC, a leading worldwide OEM manufacturer of medical- and pharmaceutical-grade polymer components and systems, announced the signing of a global partnership agreement. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
